Family study of linkage disequilibrium between TAP2 transporter and HLA class II genes. Absence of TAP2 contribution to association with insulin-dependent diabetes mellitus.

[1]  J. Trowsdale,et al.  Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAP1 and TAP2: no association in a population with a high disease incidence. , 1994, Tissue antigens.

[2]  A. Arnaiz-Villena,et al.  Susceptibility to insulin-dependent diabetes mellitus and short cytoplasmic ATP-binding domain TAP2*01 alleles. , 1994, Tissue antigens.

[3]  P. Cresswell,et al.  Human transporters associated with antigen processing possess a promiscuous peptide-binding site. , 1994, Immunity.

[4]  Günter J. Hämmerling,et al.  Selectivity of MHC-encoded peptide transporters from human, mouse and rat , 1994, Nature.

[5]  S. Tonegawa,et al.  Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator , 1994, The Journal of experimental medicine.

[6]  P. van Endert,et al.  Major Histocompatibility Complex–Encoded Antigen Processing Gene Polymorphism in IDDM , 1994, Diabetes.

[7]  E. Thorsby,et al.  Polymorphism of human major histocompatibility complex-encoded transporter associated with antigen processing (TAP) genes and susceptibility to juvenile rheumatoid arthritis. , 1994, Human Immunology.

[8]  A. Svejgaard,et al.  HLA and disease associations: detecting the strongest association. , 1994, Tissue antigens.

[9]  T. Schumacher,et al.  Peptide translocation by variants of the transporter associated with antigen processing. , 1993, Science.

[10]  P. Cresswell,et al.  Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Tonegawa,et al.  TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective , 1993, Cell.

[12]  J. Neefjes,et al.  Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. , 1993, Science.

[13]  C. Boitard,et al.  Protection from insulin‐dependent diabetes mellitus is linked to a peptide transporter gene , 1993, European journal of immunology.

[14]  J. Yewdell,et al.  Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse- human transporter , 1993, The Journal of experimental medicine.

[15]  E. Thorsby,et al.  Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin‐dependent diabetes mellitus , 1993, European journal of immunology.

[16]  S. Tonegawa,et al.  TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells , 1992, Cell.

[17]  P. van Endert,et al.  Genomic polymorphism, recombination, and linkage disequilibrium in human major histocompatibility complex-encoded antigen-processing genes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N. Huskisson,et al.  Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule , 1992, Nature.

[19]  T Spies,et al.  Allelic variants of the human putative peptide transporter involved in antigen processing. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S Beck,et al.  Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Bevan,et al.  Ham-2 corrects the class I antigen-processing defect in RMA-S cells , 1992, Nature.

[22]  P. Cresswell,et al.  Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer , 1992, Nature.

[23]  T. Elliott,et al.  Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex , 1992, Nature.

[24]  W. Klitz,et al.  Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. , 1992, Journal of immunology.

[25]  Y. Fu,et al.  Linkage of faulty major histocompatibility complex class I to autoimmune diabetes. , 1991, Science.

[26]  A. Townsend,et al.  Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter , 1991, Nature.

[27]  Robert DeMars,et al.  Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter , 1991, Nature.

[28]  J. Monaco,et al.  MHC class II region encoding proteins related to the muKidrug resistance family of transmembrane transporters , 1990, Nature.

[29]  J. Monaco,et al.  Transport protein genes in the murine MHC: possible implications for antigen processing. , 1990, Science.

[30]  R. Demars,et al.  A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway , 1990, Nature.

[31]  S. Beck,et al.  Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.

[32]  P. Cresswell,et al.  Presentation of viral antigen controlled by a gene in the major histocompatibility complex , 1990, Nature.

[33]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.